Skip to content
DefDex

Federal award

HENRY SCHEIN, INC.

HT941023P0002

Contract

Obligated and Ceiling

Obligated (net)
$1,576,508.50
Ceiling (potential value, not spending)
$1,939,130.93
Current value
$1,939,130.93
Gross positive obligations
$1,607,287.91

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
HENRY SCHEIN, INC. · D6MTSKS115L9
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
HENRY SCHEIN, INC. · D6MTSKS115L9
Awarding agency
Department of War · sub-agency 97DH · office HT9410
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
HT941023P0002
Award type code
B
Actions
11 · Oct 12, 2022 to Jun 24, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History11

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 24, 2026FY2026P00010B$5,000.00
—
May 6, 2026FY2026P00009B−$3,018.49
—
Jan 14, 2026FY2026P00008B$344,745.08
—
Sep 16, 2025FY2025P00007B$0.00
—
Jan 28, 2025FY2025P00006B−$27,760.92
—
Oct 31, 2024FY2025P00005B$432,851.84
—
Sep 11, 2024FY2024P00004G$0.00
—
Oct 13, 2023FY2024P00003C$420,812.28
—
Sep 25, 2023FY2023P00002G$0.00
—
Apr 17, 2023FY2023P00001B$9,576.65
—
Oct 12, 2022FY20230—$394,302.06
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.